Hearing Health Equity Through Accessible Research and Solutions for Korean Americans
Launched by JOHNS HOPKINS UNIVERSITY · Jan 27, 2025
Trial Information
Current as of May 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • PARTICIPANT CRITERIA Participant inclusion criteria
- • Self-identified as first-generation KA in the target region
- • Age 60 years or older
- • Has a communication partner who lives in the same household or has at least weekly interactions
- • Screening audiometry Pure-tone audiometry (PTA)1,2,4 kilohertz (kHz) \>25 decibel (dB) hearing loss (HL) in better ear
- • Hearing handicap as measured by HHIE-S score \>=8 Participant exclusion criteria
- • Current use of hearing aid
- • Medical contraindications to use amplification device (e.g., draining ear)
- • Plan to move from the area within 6 months
- • Active treatment for a terminal illness or in hospice
- • COMMUNICATION PARTNER CRITERIA Communication Partner inclusion criteria
- • Age 18 years or older
- • Able to read and speak Korean
- • Lives with the older adult or has at least weekly interactions Communication Partner exclusion criteria
- • Plan to move from the area within 6 months
- • Active treatment for a terminal illness or in hospice
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Hae-Ra Han, PhD,RN
Principal Investigator
Johns Hopkins University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported